4//SEC Filing
Saks Samuel R 4
Accession 0001209191-20-014100
CIK 0001377121other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:49 PM ET
Size
8.7 KB
Accession
0001209191-20-014100
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-28+85,000→ 85,000 totalExercise: $7.80Exp: 2030-02-27→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 48 equal monthly installments following the date of grant.
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001365615
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:49 PM ET
- Size
- 8.7 KB